Changing Neoadjuvant and Adjuvant Paradigms in HER2-Positive Breast Cancer: What Surgeons Need to Know
ESSO, Medscape
Europe/Paris GMT+2
Description
PROGRAM Friday, 16 October 2020
12:30
Introduction
Tibor Kovacs, PhD, FRCS, FEBS, Med. Habil.
12:34
The Changing Paradigm in Neoadjuvant/Adjuvant: What Is the Evidence?
Christian Jackisch, MD, PhD
12:46
Neoadjuvant or Not? What Is the Best Practice?
Fabien Reyal, MD, PhD
12:58
Assessment of Pathologic Complete Response and Residual Disease: What Is the State of the Art?
Michael Knauer, MD, PhD, FEBS
13:10
Putting It Together in Practice: What Does It All Mean for Surgeons?
Tibor Kovacs, PhD, FRCS, FEBS, Med. Habil. and Faculty Panel
13:28
So, What Do Surgeons Need to Know?
Tibor Kovacs, PhD, FRCS, FEBS, Med. Habil.
Tibor Kovacs
Introduction, The Changing Paradigm in Neoadjuvant/Adjuvant: What Is the Evidence?, Neoadjuvant or Not? What Is the Best Practice?, Assessment of Pathologic Complete Response and Residual Disease: What Is the State of the Art?, Putting It Together in Practice: What Does It All Mean for Surgeons? So, What Do Surgeons Need to Know?
Inglês
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Speakers
Christian Jackisch, Michael Knauer, Fabien Reyal
Link to the Event
Banner to the Event
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.